SLGC
Somalogic Inc
19.10$
-0.4%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -5.5% | -4.1% | -21.1% | +24.1% | +14.4% | +27.5% | +21.7% | +43.4% | +4.3% | +7.8% | +0.5% | – | |
| – | -39.1% | +46.5% | +166.2% | -39.2% | +12.4% | +9.1% | +78.6% | -49.2% | -16.3% | -40.0% | -7.0% | – | |
| – | – | -37.8% | -114.6% | – | -806.7% | – | – | +187.0% | -83.0% | -33.3% | – | – | |
| – | – | +233.8% | -216.5% | – | +263.8% | -43.9% | -252.2% | – | -206.5% | – | – | – | |
| – | -59.0% | +301.0% | +167.4% | +80.1% | -41.8% | +146.3% | -17.1% | +51.3% | -81.1% | -10.1% | -29.8% | – | |
| – | +87.4% | – | -2,909.1% | -84.6% | – | -40.5% | -168.3% | – | -27.2% | -204.9% | -52.4% | – | |
| – | – | – | – | -98.6% | +8.4% | +193.3% | – | – | -42.7% | +45.3% | – | – | |
| – | – | +0.0% | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | -99.7% | -6,433.4% | – | -99.9% | +208.2% | +193.3% | +34.1% | -93.9% | -42.7% | +45.3% | -100.0% | – | |
| – | -157.0% | – | – | -106.9% | – | -840.3% | – | – | -70.1% | -777.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.